DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,022,400 | -5.0% | 16,691 | -0.7% | 1.30% | -11.5% |
| Q1 2023 | $4,234,776 | -6.9% | 16,802 | -1.8% | 1.46% | -11.3% |
| Q4 2022 | $4,548,768 | -2.3% | 17,113 | -5.0% | 1.65% | -7.3% |
| Q3 2022 | $4,655,000 | +0.1% | 18,023 | -1.7% | 1.78% | +7.2% |
| Q2 2022 | $4,649,000 | -15.1% | 18,338 | -1.8% | 1.66% | +3.4% |
| Q1 2022 | $5,479,000 | -23.5% | 18,678 | -14.2% | 1.61% | -5.7% |
| Q4 2021 | $7,165,000 | +6.0% | 21,778 | -1.9% | 1.70% | -2.7% |
| Q3 2021 | $6,760,000 | +13.3% | 22,205 | -0.2% | 1.75% | +14.7% |
| Q2 2021 | $5,968,000 | +18.9% | 22,240 | -0.2% | 1.53% | +10.0% |
| Q1 2021 | $5,018,000 | +0.0% | 22,295 | -1.3% | 1.39% | -0.6% |
| Q4 2020 | $5,017,000 | +3.0% | 22,585 | -0.1% | 1.40% | -8.0% |
| Q3 2020 | $4,870,000 | +22.2% | 22,615 | +0.4% | 1.52% | +14.5% |
| Q2 2020 | $3,985,000 | +39.5% | 22,535 | +9.2% | 1.33% | +7.8% |
| Q1 2020 | $2,856,000 | -10.5% | 20,635 | -0.8% | 1.23% | +13.3% |
| Q4 2019 | $3,192,000 | -0.1% | 20,800 | -6.0% | 1.09% | -1.8% |
| Q3 2019 | $3,196,000 | -1.6% | 22,125 | -2.6% | 1.11% | -0.4% |
| Q2 2019 | $3,248,000 | +3.0% | 22,725 | -4.8% | 1.11% | +3.6% |
| Q1 2019 | $3,153,000 | +30.3% | 23,880 | +1.8% | 1.07% | +18.7% |
| Q4 2018 | $2,419,000 | -12.6% | 23,460 | -7.9% | 0.90% | +11.2% |
| Q3 2018 | $2,768,000 | +0.6% | 25,470 | -8.6% | 0.81% | -0.2% |
| Q2 2018 | $2,751,000 | -8.1% | 27,880 | -8.8% | 0.81% | -7.1% |
| Q1 2018 | $2,992,000 | -22.7% | 30,560 | -26.7% | 0.88% | +5.3% |
| Q4 2017 | $3,869,000 | +1.9% | 41,686 | -5.8% | 0.83% | +1.8% |
| Q3 2017 | $3,797,000 | -5.0% | 44,267 | -6.6% | 0.82% | -0.2% |
| Q2 2017 | $3,998,000 | +140.8% | 47,370 | +144.1% | 0.82% | +158.4% |
| Q1 2017 | $1,660,000 | +1.2% | 19,405 | -7.9% | 0.32% | +1.0% |
| Q4 2016 | $1,640,000 | -1.1% | 21,065 | -0.4% | 0.31% | -4.8% |
| Q3 2016 | $1,658,000 | -20.3% | 21,145 | +2.7% | 0.33% | -20.3% |
| Q2 2016 | $2,080,000 | +12.1% | 20,595 | +5.3% | 0.41% | +9.8% |
| Q1 2016 | $1,856,000 | +1.0% | 19,565 | -1.1% | 0.38% | +1.9% |
| Q4 2015 | $1,838,000 | +7.9% | 19,790 | -1.0% | 0.37% | +3.4% |
| Q3 2015 | $1,703,000 | +2.0% | 19,990 | +2.5% | 0.36% | +14.0% |
| Q2 2015 | $1,669,000 | +407.3% | 19,505 | +403.4% | 0.31% | +414.8% |
| Q1 2015 | $329,000 | +0.3% | 3,875 | +1.3% | 0.06% | +1.7% |
| Q4 2014 | $328,000 | +12.7% | 3,825 | 0.0% | 0.06% | +13.2% |
| Q3 2014 | $291,000 | -3.3% | 3,825 | 0.0% | 0.05% | +1.9% |
| Q2 2014 | $301,000 | -39.8% | 3,825 | -42.6% | 0.05% | -42.9% |
| Q1 2014 | $500,000 | -4.2% | 6,665 | -1.5% | 0.09% | 0.0% |
| Q4 2013 | $522,000 | +11.3% | 6,765 | 0.0% | 0.09% | +4.6% |
| Q3 2013 | $469,000 | +2.6% | 6,765 | -6.4% | 0.09% | +2.4% |
| Q2 2013 | $457,000 | – | 7,225 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |